not tagged
not tagged
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'reassure']
1) very important trial in #eha2022 i believe this is the first randomized #amlsm trial to report in which fit older patients were randomized to non-intensive arm (10-day dec) with no difference in os. this should reassure those worried about not giving ic to older fit patients 
Director-Heme Early Therapeutics & Leader-Leukemia/Myeloid Research @Yale. Personal views. I tweet on cancer, travel, food & soccer. COI: https://t.co/6XkF8CmtrK